Seroprevalence and Risk Factors for Toxoplasma Gondii Infection Among Pregnant Women in Northeast Iran

Overview

Journal Clin Vaccine Immunol

Publisher American Society for Microbiology

Specialties Allergy & Immunology
Pathology

Date 2013 Sep 6

PMID 24006138

Citations 11

Authors

Jalal Babaie

Samira Amiri

Ehsan Mostafavi

Nayereh Hassan

Peyman Lotfi

Ahmad Reza Esmaeili Rastaghi

Majid Golkar

Affiliations

Soon will be listed here.

Abstract

We report Toxoplasma IgG seroprevalence of 34.4% among 419 pregnant women in Mashhad, northeast Iran. Soil contact, living in rural environment, and level of education were associated with infection. The prevalence did not increase with age, suggesting high infection rate during childhood and adolescence.

Citing Articles

Cross-sectional study to investigate the seroprevalence and risk factors of among women attending the antenatal clinic in Namwala, Zambia.

Daka V, Mukosha M, Zimba S, Phiri A BMJ Open. 2024; 14(6):e084582.

PMID: 38950992 PMC: 11328639. DOI: 10.1136/bmjopen-2024-084582.

Seroprevalence and risk factors of Toxoplasmosis among HIV infected women of child-bearing age attending care and treatment clinics in Dar es Salaam, Tanzania.

Kibwana U, Manyahi J, Nkinda L, Renatus D, Kamori D, Majigo M Afr Health Sci. 2023; 22(4):470-476.

PMID: 37092062 PMC: 10117500. DOI: 10.4314/ahs.v22i4.53.

Research on demographic, clinical and paraclinical aspects in pregnant women infected with .

Csep A, Vaida L, Negrutiu B, Todor B, Judea-Pusta C, Buhas C Exp Ther Med. 2021; 23(2):123.

PMID: 34970346 PMC: 8713168. DOI: 10.3892/etm.2021.11046.

Detection of Anti- IgG and IgM Antibodies and Associated Risk Factors during Pregnancy in Southwest Iran.

Soltani S, Ghaffari A, Kahvaz M, Sabaghan M, Pashmforosh M, Foroutan M Infect Dis Obstet Gynecol. 2021; 2021:5547667.

PMID: 34135564 PMC: 8175175. DOI: 10.1155/2021/5547667.

Occurrence of antibodies and associated risk factors in women in selected districts of Punjab province, Pakistan.

Ali S, Amjad Z, Khan T, Maalik A, Iftikhar A, Khan I Parasitology. 2020; 147(10):1133-1139.

PMID: 32517832 PMC: 10317724. DOI: 10.1017/S0031182020000967.

References

Tenter A, Heckeroth A, Weiss L . Toxoplasma gondii: from animals to humans. Int J Parasitol. 2000; 30(12-13):1217-58. PMC: 3109627. DOI: 10.1016/s0020-7519(00)00124-7. View

Assmar M, Amirkhani A, Piazak N, Hovanesian A, Kooloobandi A, Etessami R . [Toxoplasmosis in Iran. Results of a seroepidemiological study]. Bull Soc Pathol Exot. 1997; 90(1):19-21. View

Mostafavi S, Ataei B, Nokhodian Z, Yaran M, Babak A . Seroepidemiology of Toxoplasma gondii infection in Isfahan province, central Iran: A population based study. J Res Med Sci. 2011; 16(4):496-501. PMC: 3214354. View

Pappas G, Roussos N, Falagas M . Toxoplasmosis snapshots: global status of Toxoplasma gondii seroprevalence and implications for pregnancy and congenital toxoplasmosis. Int J Parasitol. 2009; 39(12):1385-94. DOI: 10.1016/j.ijpara.2009.04.003. View

Ertug S, Okyay P, Turkmen M, Yuksel H . Seroprevalence and risk factors for toxoplasma infection among pregnant women in Aydin province, Turkey. BMC Public Health. 2005; 5:66. PMC: 1177966. DOI: 10.1186/1471-2458-5-66. View

Salahi-Moghaddam A, Hafizi A . A serological study on Toxoplasma gondii infection among people in south of Tehran, Iran. Korean J Parasitol. 2009; 47(1):61-3. PMC: 2655328. DOI: 10.3347/kjp.2009.47.1.61. View

Fallah M, Rabiee S, Matini M, Taherkhani H . Seroepidemiology of toxoplasmosis in primigravida women in Hamadan, Islamic Republic of Iran, 2004. East Mediterr Health J. 2008; 14(1):163-71. View

Spalding S, Amendoeira M, Klein C, Ribeiro L . Serological screening and toxoplasmosis exposure factors among pregnant women in South of Brazil. Rev Soc Bras Med Trop. 2005; 38(2):173-7. DOI: 10.1590/s0037-86822005000200009. View

Saeedi M, Veghari G, Marjani A . Seroepidemiologic evaluation of anti-toxoplasma antibodies among women in north of Iran. Pak J Biol Sci. 2008; 10(14):2359-62. DOI: 10.3923/pjbs.2007.2359.2362. View

10.

Petersen E, Vesco G, Villari S, Buffolano W . What do we know about risk factors for infection in humans with Toxoplasma gondii and how can we prevent infections?. Zoonoses Public Health. 2009; 57(1):8-17. DOI: 10.1111/j.1863-2378.2009.01278.x. View

11.

Fan C, Hung C, Su K, Sung F, Chiou H, Gil V . Seroprevalence of Toxoplasma gondii infection among pre-schoolchildren aged 1-5 years in the Democratic Republic of Sao Tome and Principe, Western Africa. Trans R Soc Trop Med Hyg. 2005; 100(5):446-9. DOI: 10.1016/j.trstmh.2005.07.013. View

12.

Youssefi M, Sefidgar A, Mostafazadeh A, Mahdavi Omran S . Serologic evaluation of toxoplasmosis in matrimonial women in Babol, Iran. Pak J Biol Sci. 2008; 10(9):1550-2. DOI: 10.3923/pjbs.2007.1550.1552. View

13.

Gras L, Gilbert R, Wallon M, Peyron F, Cortina-Borja M . Duration of the IgM response in women acquiring Toxoplasma gondii during pregnancy: implications for clinical practice and cross-sectional incidence studies. Epidemiol Infect. 2004; 132(3):541-8. PMC: 2870133. DOI: 10.1017/s0950268803001948. View

14.

Song K, Shin J, Shin H, Nam H . Seroprevalence of toxoplasmosis in Korean pregnant women. Korean J Parasitol. 2005; 43(2):69-71. PMC: 2712002. DOI: 10.3347/kjp.2005.43.2.69. View

15.

Flegr J, Hrda S, Tachezy J . The role of psychological factors in questionnaire-based studies on routes of human toxoplasmosis transmission. Cent Eur J Public Health. 1998; 6(1):45-50. View

16.

Barbosa I, Holanda C, Andrade-Neto V . Toxoplasmosis screening and risk factors amongst pregnant females in Natal, northeastern Brazil. Trans R Soc Trop Med Hyg. 2009; 103(4):377-82. DOI: 10.1016/j.trstmh.2008.11.025. View

17.

Ghorbani M, Edrissian G, Assad N . Serological survey of toxoplasmosis in the northern part of Iran, using indirect fluorescent antibody technique. Trans R Soc Trop Med Hyg. 1978; 72(4):369-71. DOI: 10.1016/0035-9203(78)90129-3. View